A series of novel bis-tetrahydropyran 1,4-triazole analogues based on the acetogenin framework display low micromolar trypanocidal activities towards both bloodstream and insect forms of Trypanosoma brucei, the causative agent of African sleeping sickness. A divergent synthetic strategy was adopted for the synthesis of the key tetrahydropyran intermediates to enable rapid access to diastereochemical variation either side of the 1,4-triazole core. The resulting diastereomeric analogues displayed varying degrees of trypanocidal activity and selectivity in structure activity relationship studies.
[INSERT FIGURE 1] The acetogenins are a class of polyketide natural products isolated from the annonaceae plant species found in the tropical regions of West Africa and South America. [6, 7] Chamuvarinin (6) was isolated in 2004 by Laurens et. al. from the roots of the bush banana plant Uvaria chamae and showed significant cytotoxicity against the KB 3-1 cervix cancer cell line (IC 50 value of 0.8 nM), shown in Figure 2 .
[8] In 2011 we reported the total synthesis of chamuvarinin, we showed that 6 and a series of synthetic derivatives exhibited low micromolar activities towards both the bloodstream and procyclic forms of T. brucei. [9] These encouraging preliminary results and the limited investigations into trypanocidal activity of the acetogenins [10] prompted our initial interest in designing simplified analogues of 6 which retain the important structural features of the acetogenin family of natural products. In an effort to reduce structural complexity it was hypothesized that a 1,4-triazole motif could form an effective spatial mimic of the central C20-C23 tetrahydrofuran (THF) motif found in chamuvarinin (6). The synthesis and incorporation of THF motifs are notoriously difficult hence, the C16-19 THF ring system of 6 was substituted with the readily accessible and manageable tetrahydropyran (THP) motif, 7, Figure 2 . The heterocyclic spacer was envisioned to arise from the "click" reaction of two THP subunits, whilst the butenolide moiety could be appended to the ether core in an analogous manner to 6 by a suitable length alkyl spacer.
[INSERT FIGURE 2] Results and Discussion
Chemistry
As outlined in Scheme 1, intermediate THP alcohols 8a and 9a could be readily assembled in three steps from (S)-epoxyoctane (10a) [11] via Cu(I)-promoted ring opening of 10a with homoallyl magnesium bromide followed by m-CPBA epoxidation and subsequent in situ acid mediated ring closure to provide a readily separable mixture of diastereomeric alcohols 8a and 9a. This divergent approach provided an excellent opportunity to introduce structural variation within the THP scaffolds. With the alcohols in hand, both diastereomers could be independently converted to the azide by Mitsunobu reaction (DPPA, DIAD, iPr 2 NEt, PPh 3 ) of alcohols 8a and 9a to give 11a and 12. [12] The enantiomeric syn azide (13) could be accessed in an analogous manner from (R)-epoxyoctane. [11] For the alkyne subunits, syn-8a and anti-9a alcohols were oxidized under Swern conditions to afford aldehydes 14a and 15a in excellent yields and subsequent exposure of 14a to OhiraBestmann homologation [13] gave exclusively syn-16a in 72% yield. Due to epimerization of aldehyde 15a under the mildly basic conditions an alternative twostep Corey-Fuchs homologation [14] approach was adopted, giving 17a in 70% yield.
The incorporation of terminal oxygenation as a functional handle for extended elaboration was achieved by synthesis of the corresponding benzylated and silylated series of azides 11b-c and alkynes 16b and 17b from epoxides 10b and 10c.
[INSERT Scheme 1] The central 1,4-triazole scaffold was conveniently installed by application of the Cu(I) catalyzed Huisgen 1,3-dipolar cycloaddition (Scheme 2).
[15]
Thus, diastereomeric analogues of the alkyl, benzylated and silylated bis-THP triazole motifs were synthesized by treatment of the corresponding azides 11a-c, 12, 13 and alkynes 16a-b, 17a-b under "click" reaction conditions (CuSO 4 , Na ascorbate) to afford triazole products 18a-d, 19a-b, 20a-b, 21a-b and 22 in good yields.
[INSERT Scheme 2] Benzylated 18b-c, 19b, 20b, 21b and 22 analogues, outlined in Scheme 3, were deprotected under atmospheric hydrogenolysis (20% Pd(OH) 2 /C, H 2 ) to the corresponding alcohols 23-28 (entries 1-6) in excellent yields.
[INSERT Scheme 3] [7] oxidation protocol.
[16] Subsequent Julia-Kocienski olefination [16] with aldehyde 30 [9, 18] and diimide reduction [19] (TsNHNH 2 , NaOAc) provided advanced analogue 31. To ascertain whether the triazole analogue would bind in a directional manner to the unknown protein target, analogue 32 was prepared in an analogous manner to 31 from alcohol 28 via sulfone 33.
[INSERT Scheme 4] Having successfully installed the butenolide motif and in an effort to further extend the SAR data, bis-directional analogue 34, outlined in Scheme 5, was synthesized in six steps from advanced triazole 18d. Silyl deprotection of 18d to alcohol 35, followed by a Mitsunobu/oxidation protocol gave sulfone 36. Julia-Kocienski olefination of sulfone 36 with 30 and subsequent diimide reduction gave triazole 37.
Benzyl deprotection of 37 with boron trichloride furnished alcohol 34 in 23% yield.
Diol analogue 38 was accessed in excellent yield from alcohol 35 under atmospheric hydrogenolysis.
[INSERT Scheme 5]
Structure-activity relationship summary
The primary mode of action for acetogenins in mammalian cells is inhibition of Complex I of the mitochondrial electron transport chain (ETC). [20] In contrast, bloodstream (BSF) T. brucei lacks functional Complexes I, III and IV and instead relies on alternative oxidases (TAO, AOX2) to enable mitochondrial respiration, while the procyclic (Pro) form expresses both a fully functional ETC and the alternative oxidases. [21] Thus in order to assess whether the triazole based analogues share a common mitochondrial target and identify key structural features required for parasitic inhibition screening against the bloodstream and procyclic forms of T. brucei and the mammalian HeLa cell line, [22] was performed (Table 1) . From the data it was evident that the stereochemistry surrounding the THP ring systems and the functionalization of the terminal motifs impacted on the T. brucei inhibition profile.
In comparison to chamuvarinin (6), the initial set of diastereomeric alkyl triazoles 20a, 21a and 18a (entries 1, 4, 7) were >17 times less potent than 6 and indicated that stereochemistry had little effect on the inhibition profile. Surprisingly analogue 19a series, implies that the benzyl group may be potentially interacting with residues at a protein target site, which an alcohol group cannot accommodate. Alternatively, or as well as the benzyl group may be able to readily insert itself into the lipophilic membrane, whereas the hydrophilic alcohol incurs a greater penalty for membrane insertion.
[Insert The synthesis of triazole analogues with terminal oxygenation has provided a functional handle for further elaboration ( Table 2 ). The non-natural chamuvarinin-like analogues previously reported revealed that introduction of the butenolide side chain resulted in a >5-fold increase in T. brucei activity. Encouraged by the potent activity of lead alcohol 23 (entry 1), it was decided to incorporate the butenolide moiety based on this structure. Analogues 31 and 32 (entries 2 and 3) clearly highlight the importance of the spatial orientation of the pendent butenolide sidechain. While 31 was essentially inactive, 32 displayed low micromolar selective activities against both forms of T. brucei with EC 50 values of 3.2 ± 0.1 and 5.7 ± 0.6 µM respectively and a selectivity index of 15.8. This suggests that although the structures are only subtly different at face value, their binding/interaction is highly specific and indicative of a protein target, rather than the biophysical properties of the compounds.
[Insert Table 2 ] -Figure containing structures to be inserted above table 2
Caption for Table 2 On the basis of the SAR data, incorporation of both the butenolide moiety and a benzyl-protected alcohol in place of the alkyl side chain indicated that the benzyl analogue 37 (entry 4) had similar activity to 32. Removal of the benzyl group to reveal the free hydroxyl analogue 34 (entry 5), was found to diminish activity and was 9 times less active than 32, with EC 50 values of 28.5 ± 4.6 and 3.2 ± 0.1 µM,
respectively. This may indicate that a non-hydrophilic arm on the opposite side of the butenolide moiety is required for maximum protein/analogue/lipid interaction.
Lipophilic efficiency
A theoretical comparison of the triazole analogues molecular properties was conducted in an effort to highlight the lipophilicity of these compounds and provide an indication as to whether they would be suitable drug candidates. As outlined in Table 3 , the data indicated that our lead compound alcohol 23 (entry 1) displayed a suitable log P of 5.163, had a molecular weight less than 500 and had a suitable number of hydrogen bond donors and acceptors, adhering to Lipinski's rule of 5.
Introduction of the butenolide moiety on one end of the THP ring system and an alkyl side chain on the opposite side in analogue 32 (entry 2), led to an increased log P value of 9. Exchange of the hydrophobic alkyl side chain with either a benzyl group (37, entry 4) or a free hydroxyl group (34, entry 3) decreased log P values while increasing the potential for hydrogen bond donation. Chamuvarinin itself (6, entry 5) displayed a high log P value of 9 in line with the observed ability of acetogenin family members to cross the blood-brain barrier [23] The lipophilic efficiency (LipE) is a combination of the calculated lipophilicity (clogP) and the potency (pEC 50 ) of analogues to estimate the drug-likeness (LipE >5) of compounds. As highlighted in Table 3 , triazoles 23, 32, 34, 37 and chamuvarinin 6 exhibited values ranging from +0.6 to -3.7, which are lower than the proposed optimal LipE of typical drug candidates. The calculated LipE values (Table 3) for triazoles 23, 32, 34, 37 and chamuvarinin 6 fall in the range +0.6 to -3.7, which although below the optimal value are in line with values often displayed by natural products and their derivatives.
[24]
Furthermore the LipE values of our designed triazole analogues are comparable with bioactive compounds that cross the blood brain barrier [23, 24] which when coupled with their toxicity towards T. brucei provides the exciting prospect of developing an effective dual pronged treatment for Stage 1 and 2 HAT if selectivity profiles can be further improved.
[INSERT 
Molecular modelling
Our initial rationale for the design and synthesis of simplified triazole analogues was based on the molecular modelling of the central tricyclic core of chamuvarinin (6), as outlined in Figure 3a , indicating that 6 adopts a "U-shape" conformation. [25] We hypothesized that a 5-membered heterocyclic spacer (Figures 3b   and 3c ) would act as an effective spatial mimic for the central THF core of 6 and thus retain potent biological activity. Modelling highlights that the lowest energy conformation of the syn-syn bis-THP rings acts a better mimic of this 'U-shaped' conformation than the corresponding anti-anti and this would appear to be broadly born out by the biological results.
[25] The encouraging trypanocidal activity of the triazole compounds discussed in this paper has now formed the basis of further design iterations and lead structure optimization. The evolving structure-activity-relationship will be enabled by further cycles of iterative design towards the development of more potent and selective trypanocidal compounds. The specific protein target and mode of action for parasite inhibition is currently undetermined for these analogues. However, analogues 31 and 32 clearly highlight that spatial orientation of the butenolide side chain impacts heavily on T. brucei inhibition. Current focus is to establish whether the analogues are disrupting mitochondrial functions through the incorporation of fluorescent and affinity tags to lead triazole compounds in order to isolate specific proteins of interest, allowing them to be genetically and chemically validated.
[INSERT FIGURE 3]

Conclusion
Experimental Section
See supporting information for full experimental details [25] Schrodinger Maestro (v9.7.014) and Macromodel (v10.4) were used for 10000
step Monte-Carlo searches using the MMFF force field. Table 2   Table 2 . Biological profiles for analogues 23, 31-32, 34 and 37, selectivity index refers to BSF parasitic inhibition versus mammalian HeLa inhibition. Table 3   Table 3 . Theoretical data of molecular properties for triazole analogues 6, 23, 32, 34
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